{
     "PMID": "24866501",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20150219",
     "LR": "20170920",
     "IS": "1432-1912 (Electronic) 0028-1298 (Linking)",
     "VI": "387",
     "IP": "7",
     "DP": "2014 Jul",
     "TI": "A pharmacological paradox: may a neutral antagonist shift an agonist concentration-response curve to the left?",
     "PG": "601-3",
     "LID": "10.1007/s00210-014-0993-1 [doi]",
     "AB": "It is generally accepted that the presence of a competitive antagonist shifts an agonist concentration-response curve to the right. However, this may not always be the case: The concentration-response curve of an inverse receptor agonist may be shifted to the left by a neutral antagonist; a condition, which can be hypothetically explained by the assumption of both negative cooperativity of dimeric receptors plus a receptor reserve.",
     "FAU": [
          "Feuerstein, Thomas J"
     ],
     "AU": [
          "Feuerstein TJ"
     ],
     "AD": "Freiburg Institute for Advanced Studies (FRIAS), University of Freiburg, 79104, Freiburg, Germany, thomas.feuerstein@uniklinik-freiburg.de.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Editorial",
          "Comment"
     ],
     "DEP": "20140528",
     "PL": "Germany",
     "TA": "Naunyn Schmiedebergs Arch Pharmacol",
     "JT": "Naunyn-Schmiedeberg's archives of pharmacology",
     "JID": "0326264",
     "RN": [
          "0",
          "((6aR,10aR)-3-(1-methansulfonylamino-4-hexyn-6-yl)6a,7,10,10a-tetrahydro-6,6,9-tr",
          "imethyl-6H-dibenzo(b,d)pyran)",
          "0 (Cannabinoid Receptor Antagonists)",
          "0 (Piperidines)",
          "0 (Pyrans)",
          "0 (Pyrazoles)",
          "0 (Receptor, Cannabinoid, CB1)",
          "7J8897W37S (Dronabinol)",
          "RML78EN3XE (rimonabant)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "CON": [
          "Naunyn Schmiedebergs Arch Pharmacol. 2014 Jul;387(7):621-8. PMID: 24853577"
     ],
     "MH": [
          "Animals",
          "Cannabinoid Receptor Antagonists/*pharmacology",
          "Dronabinol/*analogs & derivatives/pharmacology",
          "Hippocampus/*drug effects",
          "Male",
          "Norepinephrine/*metabolism",
          "Piperidines/*pharmacology",
          "Pyrans/*pharmacology",
          "Pyrazoles/*pharmacology",
          "Receptor, Cannabinoid, CB1/*metabolism"
     ],
     "EDAT": "2014/05/29 06:00",
     "MHDA": "2015/02/20 06:00",
     "CRDT": [
          "2014/05/29 06:00"
     ],
     "PHST": [
          "2014/05/14 00:00 [received]",
          "2014/05/15 00:00 [accepted]",
          "2014/05/29 06:00 [entrez]",
          "2014/05/29 06:00 [pubmed]",
          "2015/02/20 06:00 [medline]"
     ],
     "AID": [
          "10.1007/s00210-014-0993-1 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Naunyn Schmiedebergs Arch Pharmacol. 2014 Jul;387(7):601-3. doi: 10.1007/s00210-014-0993-1. Epub 2014 May 28.",
     "term": "hippocampus"
}